Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2003

Genetic analysis of maximum cigarette-use phenotypes
Nancy L. Saccone
Washington University School of Medicine in St. Louis

Rosalind J. Neuman
Washington University School of Medicine in St. Louis

Scott F. Saccone
Washington University School of Medicine in St. Louis

John P. Rice
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Saccone, Nancy L.; Neuman, Rosalind J.; Saccone, Scott F.; and Rice, John P., ,"Genetic analysis of
maximum cigarette-use phenotypes." BMC Genetics. 4,Suppl 1. S105. (2003).
https://digitalcommons.wustl.edu/open_access_pubs/135

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

BMC Genetics

BioMed Central

Open Access

Proceedings

Genetic analysis of maximum cigarette-use phenotypes
Nancy L Saccone*1, Rosalind J Neuman1,2, Scott F Saccone2 and
John P Rice1,2
Address: 1Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA and 2Department of Psychiatry,
Washington University School of Medicine, St. Louis, Missouri, USA
Email: Nancy L Saccone* - nlims@vodka.wustl.edu; Rosalind J Neuman - roz@gretta.wustl.edu; Scott F Saccone - ssaccone@han.wustl.edu;
John P Rice - john@zork.wustl.edu
* Corresponding author

from Genetic Analysis Workshop 13: Analysis of Longitudinal Family Data for Complex Diseases and Related Risk Factors
New Orleans Marriott Hotel, New Orleans, LA, USA, November 11–14, 2002
Published: 31 December 2003
<supplement>
Olson,
Lyle J Palmer,
<title>Stephen
<p>Genetic
S Rich,
Analysis
M Anne
Workshop
Spence, Jean
13: Analysis
W MacCluer</editor>
of Longitudinal</supplement>
Family Data for Complex Diseases and Related Risk Factors</p> </title> <editor>Laura Almasy, Christopher I Amos, Joan E Bailey-Wilson, Rita M Cantor, Cashell E Jaquish, Maria Martinez, Rosalind J Neuman, Jane M

BMC Genetics 2003, 4(Suppl 1):S105
This article is available from: http://www.biomedcentral.com/1471-2156/4/s1/S105

Abstract
Background: Using the Framingham Heart Study data set provided for Genetic Analysis
Workshop 13, we defined the cigarette-use phenotype M for smokers to be the maximum number
of cigarettes-per-day (MAXCIG) reported over the longitudinal course of the study. Adjustments
were made for the significant covariates of gender and year of birth, and sib-pair based linkage
analysis was performed.
Results: The primary analyses, in which individuals with MAXCIG = 0 were considered to have
missing phenotype, resulted in modest linkage evidence, with LOD scores over 1 on chromosomes
5, 9, 13, 14, and 22.
Conclusions: While the results reported here do not indicate definitive evidence for linkage to
specific chromosomal regions, future studies may find it useful to include direct assessments of
maximum and quantitative cigarette use. In defining and analyzing quantitative or "maximum use"
phenotypes, the choice of how to handle individuals with MAXCIG = 0, or alternatively, individuals
who are substance-naive, is a crucial one for genetic studies of nicotine and other substance use.
In this study, the linkage results vary greatly depending on whether or not these "unexposed"
individuals are included in the analyses.

Background
Cigarette smoking is a leading cause of premature death
and is a serious public health concern. Past studies of
smoking behavior have considered a variety of smoking
phenotypes and found that while smoking-related traits
are complex, there is evidence for significant genetic influences on smoking behavior [1,2].
The Framingham Heart Study data set provided for
Genetic Analysis Workshop 13 (GAW13) includes longitudinal data on daily cigarette use. In the past the Fram-

ingham data have been used to study important cigarette
smoking patterns such as cessation and resumption [3].
Our focus here was to define cigarette-use phenotypes that
have potential to be useful in genetic analyses. Reports
from the Collaborative Study on the Genetics of Alcoholism (COGA) have shown that the "maximum number of
drinks ever consumed in a 24 hour period" is a useful phenotype for discovering potential genetic influences on
alcohol dependence [4].
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Methods
The cigarette smoking data consist of the number of cigarettes smoked per day during periods of use in the year
prior to each exam. We have defined cigarette-use phenotypes based on these available data. However, as the
exams were (generally) 2 years apart for the original
cohort and 4 years apart for the offspring cohort, it is possible that periods of smoking behavior could have been
missed. Furthermore, no information was available on
lifetime smoking, the duration of regular smoking over
the past year, or whether the subject was still currently
smoking at each exam.
We defined a maximum number of cigarettes phenotype
M, or MAXCIG, as the maximum cigarettes-per-day
reported over all the available exams (up to 18 exams with
cigarette data for the original cohort and 5 exams for the
offspring cohort). For the purposes of the descriptive
results below, the term "smokers" refers to individuals
with M > 0, and "non-smokers" refers to individuals with
M = 0. However, it is important to note that M is not the
same as true lifetime maximum use, which cannot be
determined from the longitudinal data provided.
For genetic analyses, the primary phenotype was taken to
be the maximum number of cigarettes phenotype where
individuals with M = 0 were excluded by recording their
phenotype as "unknown." From past experience with
alcohol phenotypes we expect that defining substancenaive individuals to have unknown phenotype is most
appropriate, as individuals who have not been exposed to
a substance have unknown response; however, we also
performed parallel analyses that included M = 0 individuals for comparison. When M = 0 individuals are included,
we obtained 714 nuclear families with at least two phenotyped offspring, providing 1545 non-independent phenotyped and genotyped sib pairs. For the primary phenotype
(M = 0 considered unknown), there are 412 such nuclear
families, containing 621 non-independent phenotyped
and genotyped sib pairs.
Linear regression (using SAS, SAS Institute, Cary, NC) was
used to correct the primary maximum-cigarette phenotype for the significant covariate of gender in the initial
linkage analyses. Additional regression models adjusted
for both gender and year of birth (with linear and quadratic terms and appropriate rescaling), both with and
without interaction terms. Each of the resulting phenotypes was used for linkage analysis. Note that a similar
regression adjustment is not as appropriate in the case
where M = 0 individuals are included.
The original and offspring cohorts have different time
intervals between exams; this difference could lead to systematic differences in the resulting smoking phenotypes.
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Thus we have compared maximum cigarette use when
sampling at 2-versus 4-year intervals in the original cohort
to examine whether this difference in time interval significantly affects the resulting phenotype.
Multi-point linkage analysis was carried out on all sib
pairs (n(n-1)/2 pairs for a sibship of size n) using Haseman-Elston regression as implemented in MAPMAKER/
SIBS [5].
We also examined descriptive birth cohort effects on M.
Since the exact year of birth was not directly given in the
data, we approximated year of birth as follows: for the
original cohort the age at first exam (age 1) was subtracted
from the starting year of the study (1948); for the offspring cohort, age at first exam was subtracted from 1971,
the starting year for the offspring recruitment. Using these
definitions, there were only five men and eight women in
the sample who were born in the 1960s (and none later),
so binned cohorts were defined by decades with the
youngest cohort having a birth year in the 1950s or later.

Results
In the full sample of original cohort and offspring cohort,
M ranged from 0 to 95. For this full sample, among smokers the mean for M was 20.4 for females and 27.6 for
males.
We compared descriptive results for M for the original
cohort to the alternative phenotype Mo obtained from 4year exam intervals rather than 2-year intervals. Specifically, Mo is the maximum cigarettes-per-day reported over
all available odd-numbered exams (corresponding to
exam intervals of 4 years with 6 years between the first two
exams). Among men, 30.8% reported M = 0 versus 34.6%
who reported Mo = 0. Among women, 52.8% reported M
= 0 versus 55.0% with Mo = 0. Among smokers, a t-test
showed no significant difference between the means for M
and Mo in either gender. Hence the difference in the frequency of exams between the two cohorts does not appear
to be a serious concern in defining M.
Sib-pair correlations were significant for M, consistent
with a familial trait. The correlations were 0.25 in male
pairs (p < 0.0001), 0.33 (p < 0.0001) in female pairs, and
0.13 (p = 0.002) in male-female pairs. Lower correlation
in male-female pairs compared to same-sex pairs has similarly been observed for maximum alcohol consumption
traits [4].
Maximum cigarette use levels by gender and birth cohort
are presented in Table 1. In the regression analyses to
adjust M (with M = 0 recorded as missing) for covariate
effects, gender was highly significant (F = 115, p <
0.0001). Year of birth, tested with two degrees of freedom
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Table 1: Maximum cigarette use (%) by birth cohortA

Born:
Men
M=0
1≤M<5
5 ≤ M < 10
10 ≤ M < 20
20 ≤ M < 30
30 ≤ M < 40
40 ≤ M < 50
50 ≤ M < 60
60 ≤ M < 70
70 ≤ M < 80
M ≥ 80
Total N
Women
M=0
1≤M<5
5 ≤ M < 10
10 ≤ M < 20
20 ≤ M < 30
30 ≤ M < 40
40 ≤ M < 50
50 ≤ M < 60
60 ≤ M < 70
70 ≤ M < 80
M ≥ 80
Total N
AM

Before 1920

1910s

1920s

1930s

1940s

1950s or later

38.67
2.72
3.32
8.46
27.19
7.25
9.06
2.42
0.91
0
0
337

21.11
2.22
1.48
4.81
24.07
17.78
20.00
4.81
3.70
0
0
270

27.21
4.76
1.36
9.52
21.77
10.88
12.93
5.44
4.76
0
1.36
147

28.19
1.32
0.88
9.25
24.23
16.74
13.66
2.20
3.08
0
0.44
227

38.70
2.74
2.40
11.30
17.81
12.67
9.59
2.40
2.40
0
0
292

52.67
5.34
2.29
8.40
11.45
9.92
7.63
1.53
0.76
0
0
131

62.91
4.45
4.75
5.93
13.06
5.93
2.37
0.59
0
0
0
337

41.23
4.31
8.00
12.92
18.77
6.46
6.77
0.92
0.62
0
0
325

42.01
5.33
5.92
7.10
23.08
8.28
7.10
0.59
0.59
0
0
169

38.16
2.63
3.51
13.60
19.30
12.72
8.33
0.88
0.88
0
0
228

39.20
4.65
6.98
11.30
17.94
11.30
6.64
1.33
0.66
0
0
301

41.59
12.39
5.31
9.73
22.12
5.31
3.54
0
0
0
0
113

= maximum cigarette use over all available examinations.

for the linear and quadratic terms, was also significant
when added to the model with gender (F = 25, p <
0.0001). Finally, including interaction terms was also significant at the 0.05 level (F = 3.61, p = 0.027); this is consistent with the pattern of effects in Table 1, which
indicates that the effect of birth cohort is somewhat different for males than for females.
Linkage results are summarized in Table 2. Multi-point
linkage analyses of M corrected for gender (and M = 0
recorded as missing) resulted in LOD scores of 1.10 at 200
cM on chromosome 5, 1.67 at 173 cM on chromosome 9,
1.18 at 41 cM on chromosome 13, 1.29 at 87 cM on chromosome 14, and 1.04 at 3 cM on chromosome 22. Results
for birth-year-adjusted analyses were very similar, with a
slight increase in LOD score for chromosome 9 (1.77 for
the full-model adjusted trait).
When nonsmokers were included in the analysis, linkage
results were substantially different from those of the primary analyses above: none of the above regions gave a
LOD above 1. Instead, LODs > 1 occurred on chromosomes 6, 8, 15, 17, and 20 (Table 2).

Discussion and Conclusions
The linkage results for these maximum use phenotypes are
modest. These phenotypes were constructed from the
available longitudinal data. The motivation for defining
M was that it provided a possible cigarette-use analog to
"maximum number of drinks in 24 hours"; linkage analyses of this maximum drinks phenotype in data from the
Collaborative Study on the Genetics of Alcoholism
(COGA) indicated evidence for linkage to the region of
the alcohol dehydrogenase gene cluster on chromosome 4
[4].
Additional corrections for age effects in addition to sex
effects did not substantially affect the linkage analysis
results, even though age is clearly a significant covariate
for the maximum cigarette use phenotype studied. This
minimal impact on results could be due to the fact that
sib-pair based linkage analysis was performed; as siblings
tend to be similar in age, age-adjustment would tend to
have lesser effect on trait differences within pairs,
although scaling differences between sib pairs of different
cohorts still could have a meaningful effect.
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Table 2: Linkage results from multi-point Haseman-Elston regression.A

Covariates
Sex

Chr
M = 0 coded as
missing
5
9
13
13
14
22
M = 0 included
6
8
15
17
20
ARegions

Sex, YOBB, YOB2

Sex, YOB, YOB2,
interactions

Marker(s)

cM

LOD

cM

LOD

cM

LOD

Mfd154-164xb8
308vb1-ATA59H06
GATA86H01-GATA6B07
GATA64F08-GATA7G10
GGAA4A12-Mfd190
217xf4

200
173
41
87
3

1.10
1.67
1.18
1.29
1.04

200
172
41
88
3

1.08
1.78
1.11
1.37
1.05

200
172
41
66
88
3

1.02
1.77
1.28
1.16
1.29
1.06

242zg5
ATA19G07-GAAT1A4
GATA85D02
ATA78D02-GATA185H04
GATA47F05-321xd1

182
115
43
81

1.47
2.31
1.02
1.15

179
116
78
81

1.27
2.02
1.22
1.21

181
115
78
80

1.49
2.05
1.10
1.13

with peak LOD > 1 for at least one phenotype definition are shown. BYOB, year of birth (as described in text).

There were substantial differences in results of the linkage
analyses for which M = 0 individuals were set to missing
compared with those for which M = 0 individuals were
included. The two phenotype definitions provide very different sample sizes, and while there are a similar number
of LOD scores over 1 for each phenotype, none occur in
the same regions (across the phenotypes). There are at
least two reasons why these differences in results may be
expected. First, M = 0 is being used as a proxy to recognize
substance-naïve individuals, some of whom might nevertheless be susceptible to heavy cigarette use if suitably
exposed; thus inclusion of these individuals with a trait
value of zero could substantially alter the phenotype, in
part from an effect similar to that of misdiagnosis, with
individuals sharing genetic susceptibility having erroneously dissimilar phenotype. Second, we see from Table 1
that the percentage of individuals with M = 0 is quite high,
and including these subjects with M = 0 not only increases
the sample size dramatically, but also forces a trait distribution with properties very different from those of the distribution for M > 0 individuals only. Specifically, there is
a floor effect that is problematic for the distributional
requirements of regression analysis.
While Haseman-Elston regression is often described as a
"distribution-free" linkage method, this property is usually invoked when pointing out protection from false positives; it is worth noting that changes in and rescaling of a
trait's distribution will affect the power of an analysis to
detect a particular effect. We used classical Haseman-

Elston regression for our primary analyses due to concerns
about the distributions of the quantitative traits studied.
Besides Haseman-Elston regression, MAPMAKER/SIBS
can also be used to perform ML (maximum likelihood)
quantitative trait locus variance estimation on sib-pair
data. However, this method makes a necessary assumption of normality in the distribution for sib pairs within
each identity-by-descent (IBD) class at a locus. ML variance estimation of the sample with M = 0 set to missing
did result in LOD scores that were at least partially supportive of the Haseman-Elston findings (e.g., in sexadjusted analyses, LOD scores over 1 on chromosome 5
and chromosome 9 occurred in the same regions in Table
2, in addition to LODs over 1 on chromosomes 3 and 11).
However, when M = 0 subjects were included, results
peaked repeatedly throughout the genome, even when no
peaks were observed with Haseman-Elston regression. It
seems advisable to consider these latter ML variance
results (which included LOD scores above 5 on chromosomes 1, 11 and 20 in sex-adjusted analyses) not meaningful due to the apparent violation of distributional
assumptions.
It should be noted that the maximum cigarette phenotype
M studied here would be expected to differ from phenotypes obtained from direct questions such as "How many
cigarettes per day did you smoke during your heaviest
period of use" or "What is the largest number of cigarettes
you have ever smoked in a 24-hour period". Maximum or
quantitative cigarette-use phenotypes obtained from
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direct questions such as these may prove useful in other
studies. It also appears useful to include questions that
would permit direct identification of substance-naive or
minimally exposed individuals.
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